Tizanidine
- Product NDC
- 70518-2210
- 11-digit product format
- 705182210
- Labeler code
- 70518
- Product ID
- 70518-2210_d6a5fad6-3e40-6718-e053-2a95a90a1554
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA091283
- Marketing category
- ANDA
- Marketing start
- 2019-07-12
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-2210-1 | 70518221001 | 60 TABLET in 1 BOTTLE, PLASTIC (70518-2210-1) | 60 tablet | 2019-08-01 | 0000-00-00 | No | No | Current |
| 70518-2210-2 | 70518221002 | 30 TABLET in 1 BLISTER PACK (70518-2210-2) | 30 tablet | 2019-09-11 | 0000-00-00 | No | No | Current |